AIDS/HIV Vaccine
Codon optimization of HIV Tat enhance cell-mediated immune responses
Published in Vaccine Weekly, September 8th, 2004
"The transactivator protein, Tat, is a potential candidate for developing a vaccine against human immunodeficiency virus (HIV-1). Since Tat is not immunodominant, especially when delivered as a genetic vaccine, we expressed codon-optimized subtype-C Tat as a molecular conjugate of ubiquitin, to elicit antigen-specific cell-mediated immune responses. Immunization of mice with different ubiquitin-Tat constructs elicited a strong cellular, but not a humoral, immune response," scientists writing in the journal Vaccine report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-09-08)
More Articles from Vaccine Weekly
- Brain Cancer Vaccine
Mesenchymal stem cells have antitumor effect in rat glioma model - Cancer Vaccine
Plasmid DNA in microparticles stimulates durable T cell responses - Haemophilus Vaccine
Synthetic polysaccharide vaccine against Haemophilus influenzae developed - Influenza Vaccine
Immunostimulant patch enhances immune responses to influenza virus vaccine - Malaria Vaccine
Plasmodium antigen region elicits antibodies reactive with placental isolate - AIDS/HIV Vaccine
Candidate HIV type 1 vaccines elicit long-term memory B-cell responses - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
